Fighting with Coronavirus is becoming tough for the country and hence, the Government of India has decided to take some extra steps that can forward it to all.
Recently, the health department of India withdrew its plans to promote antibody tests on a huge scale, and now it has moved back to RT-PCR i.e. the known “gold standard” for COVID-19 Diagnosis.
However, the senior government officials also conveyed that the ICMR (Indian Council of Medical Research) could not place fresh orders for antibody rapid test kits.
Hence, instead, ICMR has asked manufacturers of Reverse Transcription Polymerase Chain Reaction (RT-PCR) kits to increase the overall production.
In addition, the ICMR also floated tenders to produce antibody test kits and RT-PCR test kits. To add more functionality, it has started going slow on antibody test production which is indeed helpful in generating results at a faster rate.
But, the overall accuracy of the antibody tests is till questioned which is why its production has been stopped. Also, India has cancelled the orders of over 2 Million test kits with a couple of Chinese firms.
What Could Be The Next Step?
ICMR has recently conveyed the domestic manufacturers of RT-PCR kits to increase the production. Though the private laboratories have less involvement in the process.
Still, an average production of 50,000 tests per day is occurring on a daily basis. However, ICMR is planning to scale up the total count to 1,00,000 tests per day in order to combat with COVID-19.
Apart from hitting difficulty with antibody test kits, the authorities failed to provide clear guidance on COVID-19. This was the overall feedback of the health experts on the authorities. Amid the COVID-19 fight, a number of complications have been presented by the government.
This includes rapid testing, plasma therapy, and even the application of hydroxychloroquine (HCQ) at various Corona Virus Test Centers. However, there are few activists who think that validating HCQ without any evidence was doubtful.
It happened because a premier health research body gives a non-evidence-based reference for a drug that was not even tested.
Conditions Of Other States
There are several states that started implementing plasma therapy on patients. But, the health ministry of India indicated that there was no enough indication to support the use of plasma therapy for COVID-19 treatment.
But, what happens in Delhi is quite different than the other states. The Chief Minister of Delhi, Mr. Arvind Kejriwal has been advising all those patients who have recovered from the coronavirus disease to donate plasma.
Because this would help serious COVID-19 patients to get rid of the disease. Believe it or not, but as per the information that has gone viral, around 350 Tablighi Jamaat members who got completely recovered from the infection donated their plasma.
The therapy had proved to benefit people and the Delhi government did the implementations later on by conducting a trial and planning to expand it.
Some Decisions Proved Jumbling
To learn more, you can take the case of HCQ and ibuprofen. Talking about asymptomatic or pre-symptomatic personalities, all such names have a scientific meaning. And we are now using it for public relations.
Additionally, common persons like us and even the doctors are finding it difficult to differentiate between PR and science.
The main issue occurs then when some of the information provided by the Government says that HCQ cannot be exported and the very next moment the ban on the medicine lifts up.
Afterwards, people start getting admitted, and then anytime a notice comes out that people with mild symptoms can stay at home.
So, basically, if you think there is no clear plan but science has a plan. So, such kind of misunderstandings may create a huge fiasco for all.
However, the public health experts also conveyed that from inadequate testing and huge lack of coordination, the activities showed a jumbled response to the coronavirus disease.
Initially, it was unknown what will be the strategy for Coronavirus Testing and what is the correct time to start with the rapid testing.
The main issue raised when the Indian Government’s refused to provide vivid directions on a number of aspects and then the rules came out to be quite confusing.
The Final Effect
As per the decision taken by ICMR and the Government of India, the rapid test kits are created to increase the screening procedure in the country of around 1.3 billion people.
However, the Union Ministry of Health said that, in such regions, close to 70% of testing capacity has been wholly established.
If you talk about last month, then only 80,000 people could take the COVID-19 test at various Coronavirus Test Centers across India. However, there could be only 132 state-run labs along with 52 private labs. Then, the total number of tests accompanied increased to around 10,000 per day.
With the help of all these initiatives taken by the Government, India is all set and planned to achieve a greater, faster, and accurate diagnosis of the COVID-19 treatment.
However, still, people are advised to stay home and follow the basic guidelines issued by the government in the respective states and regions.
ICMR has approved a number of COVID-19 testing labs in India and Metropolis Healthcare is among them. It is the best and authorized Corona Virus Testing Lab in India spread across various regions of Maharashtra.
One can go and visit the lab to get tested with coronavirus. But, importantly, one should have a prescription from the experienced and knowledgeable doctors and have to follow a couple of more instructions.